Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –– Extends ...
Today, Cineplex Inc. (“Cineplex” or the “Company”) released its financial results for the three months ended March 31, 2026. Unless otherwise specified, all amounts contained in this news release are ...
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Canadian ...
Total Orders -- Grew 3% year over year, with repeat orders outperforming total growth. Average Order Value -- $2,131, an ...
Today, Cineplex Inc. ("Cineplex" or the "Company") released its financial results for the three months ended March 31, 2026. Unless otherwise specified, all ...
California auto headwinds, Florida refunds, rate hikes, $60M cost saves and 2H outlook—read the key takeaways.
Collegium Pharmaceutical, Inc.: Collegium Completes Acquisition of AZSTARYS from Corium Therapeutics
Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio - - Extends Collegium's Long-Term Revenue Outlook; AZSTARYS has Expected ...
MarketBeat on MSN
Chimera Investment Q1 Earnings Call Highlights
Chimera Investment (NYSE:CIM) executives said the company covered its dividend in the first quarter of 2026 while continuing to reposition its portfolio toward more liquid assets and expanding its ...
Thursday, May 7, 2026 at 11:00 a.m. ET President and Chief Investment Officer — Gregg Bresner Net Investment Income -- $0.25 ...
As a REIF-specific ETF, REM offsets risk via diversification in its portfolio to avoid elevated single company risk.
Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results